Pill to Counter Postpartum Depression Looks Good in Trial, May Gain FDA Approval
WEDNESDAY, Aug. 2, 2023 (HealthDay News) — All eyes are on the U.S. Food and Drug Administration this week as the agency weighs approval of a new pill that may quickly treat and ease severe postpartum depression. Approval of the drug could help millions of women regain their emotional equilibriumContinue Reading














